The feasibility of the injection moulding (IM) was explored for the development of novel drug delivery systems. Controlled release formulations were developed using a substituted cellulose derivative, hydroxypropyl methyl cellulose acetate succinate (HPMCAS) and a graft co-polymer (Soluplus®). BCS class II drugs ibuprofen and the felodipine were selected based on their physicochemical properties. In the present work, a homogenous dispersion of drugs in the polymer matrices was achieved using Hot Melt Extrusion (HME) and extruded pellets obtained were used for the development of the injection moulded systems. Four systems were developed using the IM consisting of ibuprofen-HPMCAS, ibuprofen-Soluplus®, felodipine-PEO-HPMCAS and felodipine-Soluplus®. The ibuprofen acts as a good plasticiser compared to felodipine therefore, felodipine containing IM systems required a plasticiser (PEO) when processed with HPMCAS. The analysis of extruded pellets and injection moulded systems using modulated DSC (MDSC) and Raman spectroscopy confirmed the formation of an amorphous molecular dispersion (i.e solid solution) in the case of all four systems. The phase separation behaviour and the amorphous stability of the systems was studied at various stress conditions. This revealed the “surface crystallisation” behaviour of the ibuprofen-HPMCAS systems. Temperature-composition phase diagram constructed based on the melting point depression and the Flory-Huggins lattice solution theory provided the explanation for the phase separation and crystallisation behaviour of ibuprofen-HPMCAS systems. The advanced characterisation techniques like DMA, 2D XRD and 3D laser microscopy provided the detailed understanding of crystal habits, phase seperation and surface crystallisation. The significant effect of the stress conditions on the rate of shrinkage was observed where, higher shrinkage tendency of a HPMCAS IM system was observed compared to Soluplus® IM systems. The extruded pellets provided the faster drug release compared to the moulded tablets suggests the effect of particle size as well as the densification during IM on the dissolution rate of the dosage form. The nature of the polymer and processing history were the contributing factors for the dissolution of the dosage forms.

This research is the first systematic investigation of solid-state orientation as a novel method for controlling drug release from biodegradable polymers. The effect of various degrees of polymer orientation was studied in oriented Poly (L-lactic acid) (PLA) films containing curcumin and theophylline as model drugs. Additionally, direction specific drug release was studied from oriented PLA rods containing paracetamol. The films oriented to 2X uniaxial constant width (UCW) or 2X2Y biaxial draw ratio showed retardation of drug release, when their nematic structure was stabilised by the presence of crystalline theophylline. Contrarily, the same films when contained solid solution of curcumin, shrunk in the release medium and exhibited a release profile similar to the un-oriented films. All films oriented to the UCW draw ratio ≥ 3X contained α crystalline form of PLA and showed acceleration of drug release proportionate to the draw ratio. According to the proposed mechanism augmented formation of water filled channels in these films was responsible for faster drug release. Similarly, the paracetamol loaded PLA rods die-drawn to uniaxial draw ratios ≥ 3X exhibited enhancement of drug release. Importantly, the amount of drug released along the oriented chain axis was significantly larger than that in the perpendicular direction. Drug release from the die-drawn rods was accelerated by a greater degree than that observed from the oriented films. This can be correlated to the differences in their size, geometry and the crystalline form of PLA. In conclusion, the current study provided substantial evidence that solid-state orientation can offer a control over drug release from PLA.

A zidovudina (AZT) ainda é o fármaco mais empregado no tratamento da AIDS, isoladamente ou em associação a outros antirretrovirais, porém é um fármaco administrado em altas doses e que apresenta efeitos adversos que comprometem a adesão do paciente ao tratamento. Assim, um novo sistema de liberação de zidovudina composto por nanopartículas de poli (n-butil-cianoacrilato) (PBCA) revestidas por ácido hialurônico (AH) foi desenvolvido e caracterizado com o objetivo de prolongar a liberação do fármaco e diminuir sua toxicidade. As nanopartículas têm sido amplamente estudadas como veículo para fármacos por permanecer na circulação por um tempo maior e, portanto, liberar o fármaco de forma prolongada. Para polimerização e, portanto, obtenção das nanopartículas, n-butil-cianoacrilato e Dextran® foram adicionados a HCl 0,1 M (pH 2,5), sob agitação a 800 rpm, por 1 h. O AZT foi adicionado e o processo foi neutralizado com adição de NaOH 0,1M após mais 3 h de agitação. Após filtração as partículas foram revestidas pela adição de uma dispersão aquosa de ácido hialurônico (AH) a baixa rotação. O diâmetro hidrodinâmico médio das nanopartículas não revestidas foi de 152,3 nm, com um índice de polidispersividade médio igual a 0,055. O potencial zeta médio dessas partículas foi -0,678 mV. O diâmetro hidrodinâmico médio das nanopartículas revestidas com AH obtido foi de 196,9 nm, com um índice de polidispersividade médio igual a 0,440. O potencial zeta médio dessas partículas foi de -25,6 mV. Os valores resultantes dessas análises são indicativos da estabilidade das nanopartículas obtidas e da boa reatividade dos monômeros dos cianoacrilatos. Ainda, pelos resultados é possível confirmar a ocorrência do revestimento. Assim, a eficiência do processo de revestimento das nanopartículas pode ser comprovada por meio dos resultados das análises de calorimetria exploratória diferencial (DSC) e pelos resultados das análises de espectroscopia de absorção na região do infravermelho. Para quantificar o fármaco associado às nanopartículas, um método empregando espectrofotometria derivada (ED1) no UV aplicando a técnica do ponto de anulação foi desenvolvido e validado. Tal método possibilitou a eliminação da interferência dos excipientes, o que permitiu a quantificação do AZT na suspensão de nanopartículas com precisão e exatidão adequadas. A porcentagem de fármaco associado às nanoestruturas obtidas pelo método foi de 64%, considerado satisfatório. As nanopartículas foram incorporadas a uma formulação base de gel de Carbopol® 940 que, apresentou estabilidade após ser submetida a diferentes condições de armazenamento, com incidência de luz e variação da temperatura. / Zidovudine (AZT) is still the most widely used drug in the treatment of AIDS, alone or in combination with other antiretroviral drugs, however it is indicated in high doses and has adverse effects that compromise patient compliance to treatment. Thus, a new zidovudine delivery system made of poly (n-butyl-cyanoacrylate) nanoparticles coated with hyaluronic acid (HA) was developed and characterized in order to extend the drug release and reduce its toxicity. The nanoparticles have been widely studied as drug carriers once they remain in circulation for a longer period and, consequently, release the drug gradually. For the polymerization, and, therefore synthesis of nanoparticles, n-butyl-cyanoacrylate and Dextran® were added to 0.1 M HCl (pH 2.5) and stirred at 800 rpm for 1 hour. AZT was added and the reaction was neutralized by the addition of 0.1 M NaOH after 3 more hours of agitation. After filtration the particles were coated by addition of an aqueous dispersion of hyaluronic acid (HA) at low revs. The mean hydrodynamic diameter of non-coated nanoparticles was 152.3 nm with an average polydispersity index of 0.055. The average zeta potential of these particles was -0.678 mV. The average hydrodynamic diameter of the coated nanoparticles was 196.9 nm, presenting an average polydispersity index of 0.440. The average zeta potential of these particles was -25.6 mV. The resulting values of these tests are indicative not only of the stability of the obtained nanoparticles but also the good reactivity of the monomers of cyanoacrylates. Moreover, the results can confirm the occurrence of coating. Thus, the efficiency of the coating process of the nanoparticles can be demonstrated by the results of the analysis of differential scanning calorimetry (DSC) and the results of the absorption spectroscopy in the infrared region. In order to quantify the drug associated with the nanoparticles, a method employing derivative spectrophotometry (ED1) UV applying the zero-crossing technique was developed and validated. This method allowed the elimination of interference of excipientes, allowing the quantification of AZT nanoparticles in suspension with adequate accuracy and precision. The percentage of the drug associated with the obtained nanostructures by the method was 64%. The nanoparticles were incorporated into a Carbopol® 940 gel formulation, which was stable after being subjected to different storage conditions, with incidence of light and temperature variation.

CoordenaÃÃo de AperfeiÃoamento de Pessoal de NÃvel Superior / Os alquilglicosÃdeos constituem uma nova e interessante classe de surfactantes por serem biodegradÃveis, atÃxicos e sintetizados a partir de fontes renovÃveis e abundantes na natureza. Estas propriedades os tornam potencialmente mais apropriados que outros surfactantes os quais prejudicam o meio ambiente. O presente trabalho trata da sÃntese e caracterizaÃÃo de duas sÃries de alquilglicosÃdeos utilizando os Ãlcoois C10, C16 e C18 como parte hidrofÃbica e glicose e derivados da degradaÃÃo da amilose como partes hidrofÃlicas. A sÃntese dos alquilglicosÃdeos foi realizada atravÃs da reaÃÃo usual de KÃenig-Knorr com algumas modificaÃÃes. A caracterizaÃÃo estrutural dos surfactantes foi acompanhada por ressonÃncia magnÃtica nuclear 1H, 13C (RMN) juntamente com a espectroscopia de absorÃÃo na regiÃo do infravermelho (IV). Os estudos de RMN e IV permitiram caracterizar detalhadamente as junÃÃes entre os grupos hidrofÃlicos e hidrofÃbicos, como predominantemente glicosÃdica. A cromatografia de permeaÃÃo de gel (GPC) mostrou evidÃncias da formaÃÃo dos surfactantes com aproximadamente cinco anÃis glicosÃdicos ligados à cadeia alquÃlica. Estruturas de cristais lÃquidos, identificadas pela presenÃa de pontos de fusÃo duplos, foram observadas atravÃs da tÃcnica de calorimetria exploratÃria diferencial (DSC), revelando as propriedades termotrÃpicas dos surfactantes. O mÃtodo de du NoÃy foi utilizado para determinar a tensÃo superficial e concentraÃÃo micelar crÃtica (cmc) das soluÃÃes aquosas Ãs vÃrias concentraÃÃes. Observou-se que para as duas sÃries de surfactantes, o aumento do comprimento da cadeia alquÃlica levou à reduÃÃo esperada da cmc. As energias envolvidas nos processos de adsorÃÃo e micelizaÃÃo calculadas a partir das isotermas de tensÃo superficial de equilÃbrio versus ln da concentraÃÃo indicam a cooperatividade dos grupos hidrofÃlicos e hidrofÃbicos nestes processos. / Alkyl glucosides constitute a new and interesting class of surfactants, as they are biodegradable, nontoxic, and synthesized from renewable resources. These properties make them substitutes for other surfactants which are potentially damaging to the environment. The present work deals with the synthesis and characterization of two series of alkyl glucosides, which used C10, C16 and C18 alcohols as the hydrophobic part and glucose and glucose residues derived from degradation of amylose (which was essentially free from amilopectin) as hydrophilics parts. The alkyl glucosides synthesis was performed by the usual KÃenigs-Knorr reaction with some modifications. The molecular structures of the surfactants were characterized by 1H, 13C nuclear magnetic resonance (NMR) together with infra-red (IR) spectroscopy. The study by NMR and IR allowed the junctions between hydrophilic head-groups and hydrophobic tailgroups to be characterized predominantly as -glycosidic. Gel permeation chromatography (GPC) showed evidences of the formation of the surfactants with five glucosides rings linked to the alkyl chain. Liquid crystals structures were investigated by the differential scanning calorimetry (DSC) technique confirming the characteristics of thermotropics properties, through the presence of double melting points. The du NoÃy method was used to determine the surface-tension and critical micelle concentration (cmc) of aqueous solutions at various concentrations. For the two series of surfactants, it was observed that the increase of the alkyl chain caused the already expected decrease of cmc. The energies involved in the adsorption and micellization process calculated from the equilibrium surface tension isotherm versus ln concentration indicates co-operativety from the hydrophilics and hydrophobics grups.

Zhang, Xinran. / Thesis submitted in: December 2007. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2008. / Includes bibliographical references (leaves 80-87). / Abstracts in English and Chinese. / TITLE PAGE --- p.i / ABSTRACT --- p.ii / 中文摘要 --- p.v / ACKNOWLEDGEMENTS --- p.vii / TABLE OF CONTENTS --- p.viii / LIST OF FIGURES --- p.xi / LIST OF TABLES --- p.xiv / ABBREVIATIONS --- p.xv / Chapter CHAPTER 1. --- Introduction / Chapter 1.1. --- Rationale of the Study --- p.1 / Chapter 1.2. --- Current technologies for formulating long-acting parenteral protein deliver system --- p.3 / Chapter 1.2.1. --- Chemical Modification --- p.3 / Chapter 1.2.2. --- Sustained-release formulation --- p.4 / Chapter 1.2.2.1. --- Phase separation method --- p.4 / Chapter 1.2.2.2. --- Solvent evaporation/extraction method --- p.5 / Chapter 1.2.2.3. --- Spray drying method --- p.6 / Chapter 1.2.2.4. --- Causes for protein instability --- p.6 / Chapter 1.2.2.4.1. --- Water/organic solvent interface --- p.6 / Chapter 1.2.2.4.2. --- Lyophilization --- p.8 / Chapter 1.2.2.4.3. --- Polymer --- p.11 / Chapter 1.2.2.4.4. --- Stabilizing additive --- p.13 / Chapter 1.3. --- Aqueous-aqueous emulsion technology --- p.17 / Chapter 1.3.1. --- Background --- p.17 / Chapter 1.3.2. --- Basic Principle --- p.17 / Chapter 1.3.3. --- Phase diagram --- p.18 / Chapter 1.3.4. --- Formation of aqueous-aqueous emulsion --- p.19 / Chapter 1.3.4.1. --- Introduction of a water-soluble charged polymer as stabilizer --- p.19 / Chapter 1.3.4.2. --- Freezing-induced phase separation --- p.20 / Chapter 1.3.5. --- General Protocol --- p.21 / Chapter 1.3.5.1. --- Introduction of a water-soluble charged polymeric stabilizer --- p.22 / Chapter 1.3.5.2. --- Freezing-induced phase separation --- p.22 / Chapter 1.3.6. --- Merits and limitations of the aqueous-aqueous emulsion technology --- p.23 / Chapter 1.3.7. --- Protein selection for the sustained release formulation --- p.25 / Chapter 1.4. --- Aims and scope of study --- p.26 / Chapter "CHAPTER 2," --- Materials and Methods / Chapter 2.1. --- Materials --- p.28 / Chapter 2.1.1. --- Proteins --- p.28 / Chapter 2.1.2. --- Polymers --- p.28 / Chapter 2.1.3. --- Media for TF-1 Cell Culture --- p.28 / Chapter 2.1.4. --- Chemicals and Solvents for Cell Proliferation Assay --- p.29 / Chapter 2.1.5. --- Other Chemicals and Solvents --- p.29 / Chapter 2.1.6. --- Materials for Cell Culture --- p.29 / Chapter 2.1.7. --- Materials for Reagent Kits --- p.30 / Chapter 2.2. --- Methods --- p.30 / Chapter 2.2.1. --- Determination of the Partition Coefficients of Proteins Between PEG and Dextran --- p.30 / Chapter 2.2.2. --- Preparation of Glassy Particles --- p.31 / Chapter 2.2.2.1. --- Standard Stable Aqueous-aqueous Emulsion Method --- p.31 / Chapter 2.2.2.2. --- Freezing-induced Phase Separation --- p.32 / Chapter 2.2.3. --- Preparation of Protein-loaded and Blank Microspheres Using S-o-w Solvent Extraction Technique --- p.32 / Chapter 2.2.4. --- Optical Microscopy and Scanning Electron Microscopy --- p.33 / Chapter 2.2.5. --- Determination of Protein Loading --- p.34 / Chapter 2.2.5.1. --- Within Dextran Particles --- p.34 / Chapter 2.2.5.2. --- Within PLGA microspheres --- p.34 / Chapter 2.2.6. --- Evaluation of Protein Structural Integrity and Bioactivity in Dextran Particles and PGLA Microspheres --- p.35 / Chapter 2.2.7. --- In vitro Release Study --- p.36 / Chapter 2.2.8. --- RhIFN Stability Determination under Simulated In Vitro Release Conditions --- p.37 / Chapter 2.2.8.1. --- In the Absence of PLGA --- p.37 / Chapter 2.2.8.2. --- In the Presence of PLGA --- p.37 / Chapter 2.2.9. --- MicroBCÁёØ Protein Assay --- p.38 / Chapter 2.2.10. --- Size Exclusion Chromatography (SEC) - High Performance Liquid Chromatography (HPLC) --- p.38 / Chapter 2.2.11. --- ELISA --- p.39 / Chapter 2.2.12. --- Bioactivity Assay --- p.40 / Chapter 2.2.12.1. --- RhIFN --- p.40 / Chapter 2.2.12.2. --- RhGM-CSF --- p.41 / Chapter CHAPTER 3. --- Results and Discussions / Chapter 3.1. --- Sustained-release RhIFN Formulation --- p.45 / Chapter 3.1.1. --- Partition Coefficient of RhIFN --- p.45 / Chapter 3.1.2. --- Formulation Based on the Standard Aqueous-aqueous Emulsion (SA-AE) Method With Sodium Alginate as Stabilizer --- p.45 / Chapter 3.1.2.1. --- Surface Morphology --- p.45 / Chapter 3.1.2.2. --- Formulation Characterization --- p.46 / Chapter 3.1.2.3. --- In Vitro Release of RhIFN from PLGA Microsheres --- p.54 / Chapter 3.1.3. --- Formulation Based on the Freezing-induced Phase Separation (FIPS) Technique without Sodium Alginate --- p.56 / Chapter 3.1.3.1. --- Formulation Characterization --- p.56 / Chapter 3.1.3.2. --- In Vitro Release of RhIFN from PGLA Microsphees --- p.59 / Chapter 3.2. --- RhIFN Stability Assessment under Simulated In Vitro Release Conditions --- p.63 / Chapter 3.2.1. --- In the Absence of PLGA --- p.63 / Chapter 3.2.2. --- In the Presence of PLGA --- p.65 / Chapter 3.3. --- Sustained-release RhGM-CSF Formulation --- p.68 / Chapter 3.3.1. --- Partition Coefficient Determination of RhGM-CSF Between PEG and Dextran --- p.68 / Chapter 3.3.2. --- Formulation Based on Freezing-induced Phase Separation --- p.68 / Chapter 3.3.2.1. --- Validation of MTT Assay Conditions --- p.69 / Chapter 3.3.2.2. --- Formulation Characterization --- p.71 / Chapter 3.3.2.3. --- In Vitro Release of RhGM-CSF from PLGA Microspheres --- p.75 / Chapter CHAPTER 4. --- Conclusion and Future Studies / Chapter 4.1. --- Conclusion --- p.78 / Chapter 4.2. --- Future Studies --- p.79 / References --- p.80

This thesis investigates the feasibility of loading silicone hydrogel (SiHy) contact lenses with two different hydrophobic therapeutics, latanoprost and DMPC (1,2-dimyristoyl-sn-glycero-3-phosphocholine), for treatment of glaucoma and hyperemia respectively. The two methods of loading were 1) thermal loading in an aqueous medium and 2) convective loading in a solution of n-propanol. Dailies Total1® lenses prepared in this manner were tested for their loading and their release into artificial tears. Continuous release over 1-4 days at therapeutic levels is achievable from thermal loading of DMPC, convective loading of DMPC, and convective loading of latanoprost. The DMPC loading processes can be naturally integrated into standard manufacturing lines for Dailies Total1®. Both DMPC and latanoprost release at rates proportional to the amount loaded into a contact lens. Latanoprost loads into a contact lens strictly proportionally to the loading concentration and the time of loading. The convective loading step represents a significant improvement on both the time of loading (reduced from days to minutes) and the loading capacity of silicone hydrogel contact lenses. This thesis also compares the loading and release of latanoprost in the convective loading procedure using the SiHy contact lenses of Acuvue Advance® (Johnson & Johnson Vision Care, Jacksonville, FL) , Air Optix® (Alcon, Copenhagen, Denmark), Biofinity® (CooperVision), PureVision® (Bausch & Lomb), and Dailies Total1® (Alcon), and the polyHEMA lens, SofLens 38® (Bausch & Lomb), finding that silicone hydrogels load an order of magnitude more drug than the polyHEMA lens and release into artificial tears for an order of magnitude longer. Overall, these experiments provide a quantitative understanding of the dynamics of loading and release for both DMPC and latanoprost.

Sustainable landscaping includes utilization of plants requiring few inputs. We chose four species showing potential for use in arid landscapes: Purshia mexicana, Shepherdia argentea, Shepherdia rotundifolia, and Alnus maritima. We sowed seeds of S. rotundifolia, S. argentea and P. mexicana in three substrates with various water-holding properties due to differing amounts of organic matter (OM). S. rotundifolia germination was maximized in a calcined clay (66.2%) containing no OM and had low germination (12.7 - 21.8%) in the other substrates. S. argentea germination (42.3 to 53.7%) was similar in all substrates. Poor seed quality of P. mexicana resulted in inconclusive results. Our results suggest that germination of some species is enhanced by substrates with excellent drainage properties. We also investigated effects of different rates of controlled-release fertilizer (CRF) on symbiotic nodule formation in seaside alder. We found that lower than prescribed rates of CRF enhanced nodulation without compromising nitrogen status.

La nanotechnologie possède la potentialité d’améliorer la sécurité, les procédés, l’emballage alimentaire et le concept d’ingrédient fonctionnel. La nano-encapsulation d’agents actifs, est un concept innovant permettant de protéger les agents actifs d’une dégradation éventuelle pendant le procédé de fabrication de l’aliment et son stockage. Le principal objectif de ce travail est de développer et d’optimiser une méthode de marquage fluorescent afin d’effectuer des études de transfert dans différents films de bio-polymères et dans l’aliment et de nano-encapsuler la nisine. La nano-encapsulation de la nisine dans différents nano-liposomes par micro-fluidisation (CCDS) est une technique innovante pour la fabrication de nano-systèmes de re-largage. L’incorporation de nisine sous forme de nano-émulsion est une méthode efficace de contrôle des flores pathogènes sans altérer les caractéristiques des films d’HPMC. La nisine Z a été marquée par un composé fluorescent, et a une masse moléculaire de 3713,3. Des études en microscopie confocale ont permis de démontrer que l’interaction de la nisine avec les membranes bactériennes se situait au niveau de site de division de la cellule. L’HPMC, le chitosane, le caséinate et l’acide poly-lactique agissent comme des réservoirs et libèrent progressivement la nisine afin d’obtenir un effet inhibiteur durable. Le choix du biopolymère affecte la biodispinibilité du composé à la surface et à l’intérieur de l’aliment. La prochaine révolution concernant la sécurité alimentaire par l’emballage mettra en avant le dernier concept technologique « 3-BIOs » qui se réfère aux notions Bioactif - Biodégradable - Bionanocomposite / Food nanotechnology has the potential to improve food safety and bio-security, food processing, food packaging and functional ingredients. Nano-encapsulation of active agents is an innovative concept to protect them against possible denaturation during processing and storage. The overall objective of the present work was to optimize and develop fluorescent labeling and encapsulation of nisin for molecular transfer study in different packaging based on biopolymers and in the food. Nanoencapsulation of nisin in different nanoliposomes by using continuous cell disruption system (CCDS) has provided an innovative method for nano-delivery systems fabrication. Incorporation of nisin in nano-emulsion form (encapsulated and free) can possibly be an effective approach to control pathogen without compromising the basic physico-chemical attributes of composite HPMC coatings. The fluorescently labeled nisin Z prepared had a molecular weight of 3717.3 Da. Confocal microscopic studies demonstrated the interaction of nisin with the bacterial membranes at the cell-division sites as possible mechanism of action against food borne pathogen. HPMC, CTS, SC and PLA packaging bio-membranes act as a reservoir and progressively release nisin to sustain a constant inhibitory effect. Choice of biopolymer is significant in providing requisite bioavailability of antimicrobial compounds at exterior surface and inside the food system. Based on the present study results, the emerging revolution concerning food safety through packaging possibly will rely on « 3-BIOs » blend with nanotechnology, which refers to Bioactive, Biodegradable and Bio-nanocomposite

Peripheral vascular diseases such as peripheral artery disease (PAD) and critical limb ischemia (CLI) are growing at an ever-increasing rate in the Western world due to an aging population and the incidence of type II diabetes. A growing economic burden continues because these diseases are common indicators of future heart attack or stroke. Common therapies are generally limited to pharmacologic agents or endovascular therapies which have had mixed results still ending in necrosis or limb loss. Therapeutic angiogenic strategies have become welcome options for patients suffering from PAD due to the restoration of blood flow in the extremities. Capillary sprouting and a return to normoxic tissue states are also demonstrated by the use of angiogenic cytokines in conjunction with bone marrow cell populations. To this point, it has been determined that spatial and temporal controlled release of growth factors from vehicles provides a greater therapeutic and angiogenic effect than growth factors delivered intramuscularly, intravenously, or intraarterialy due to rapid metabolization of the cytokine, and non-targeted release. Furthermore, bone marrow cells have been implicated to enhance angiogenesis in numerous ischemic diseases due to their ability to secrete angiogenic cytokines and their numerous cell fractions present which are implicated to promote mature vessel formation. Use of angiogenic peptides, in conjunction with bone marrow cells, has been hypothesized in EPC mobilization from the periphery and marrow tissues to facilitate neovessel formation. For this purpose, controlled release of angiogenic peptides basic fibroblast growth factor (FGF-2) and granulocyte-colony stimulating factor (G-CSF) was performed using tunable ionic gelatin hydrogels or fibrin scaffolds with ionic albumin microspheres. The proliferation of endothelial cell culture was determined to have an enhanced effect based on altering concentrations of growth factors and method of release: co-delivery versus sequential. Scaffolds with these angiogenic peptides were implanted in young balb/c mice that underwent unilateral hindlimb ischemia by ligation and excision of the femoral artery. Endpoints for hindlimb reperfusion and angiogenesis were determined by Laser Doppler Perfusion Imaging and immunohistochemical staining for capillaries (CD-31) and smooth muscle cells (alpha-SMA). In addition to controlled release of angiogenic peptides, further studies combined the use of a fibrin co-delivery scaffold with FGF-2 and G-CSF with bone marrow stem cell transplantation to enhance vessel formation following CLI. Endpoints also included lipophilic vascular painting to evaluate the extent of angiogenesis and arteriogenesis in an ischemic hindlimb. Tissue engineering strategies utilizing bone marrow cells and angiogenic peptides demonstrate improved hindlimb blood flow compared to BM cells or cytokines alone, as well as enhanced angiogenesis based on immunohistochemical staining and vessel densities.

Applications in controlled release and delivery calls for a good understanding of molecular transport within the carrier material and the dominating release mechanisms. It is clear that a better understanding of hindered transport and diffusion of guest molecules is important when developing new porous materials, e.g., surfactant templated silica spheres, for biotechnological applications. Confocal laser scanning microscopy was used to quantify the bulk release and intraparticle transport of small charged fluorescent dyes, and fluorescently-tagged neutral dextran, from mesoporous silica spheres. The time dependent release and the concentration profiles within the spheres have been used to analyze the release mechanisms using appropriate models. While the small, non-adsorbing anionic dye is released following a simple diffusion driven process, the concentration of the cationic dye varies radially within the spheres after loading. The release of the cationic dye is controlled by diffusion after an initial period of rapid release, which could be due to a significant fraction of the cationic dye that remains permanently attached to the negatively charged walls of the mesoporous silica spheres. The diffusion of dextran and the resulting flat concentration profiles could be related to the complex structural feature of the cylindrical pores close to the surface, and a possible conformational change of the dextran with the concentration. The stability and leaching of a catalytic enzyme, lipase, immobilized in hydrophobilized mesoporous support has also been quantified. Colloidal monodisperse mesoporous silica spheres were synthesized and transmission electron microscopy showed that the inner pore structure display a radially extending pores. The mesoporous spheres were used as solid supports for a lipid membrane incorporated with a multi-subunit redox-driven proton pump, which was shown to remain functional. / Synthesis, functionalisation and controlled release of mesoporous materials